#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia Alzheimer's type Myxoid liposarcoma Acute myeloid leukaemia recurrent Inclusion body myositis Prolymphocytic leukaemia Craniopharyngioma Squamous cell carcinoma of head and neck Hidradenitis Encephalitis autoimmune Vulval cancer recurrent Cutaneous T-cell lymphoma stage I Osteopetrosis Urea cycle disorder Medulloblastoma Congenital cystic kidney disease More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Life with Disease Alagille syndrome – Treatment Cytokine release syndrome Langerhans cell sarcoma – Treatment Propionic acidaemia – Trials in Disease Mantle cell lymphoma refractory – Life with Disease Systemic sclerosis pulmonary – Life with Disease Familial amyotrophic lateral sclerosis – Treatment Mantle cell lymphoma stage IV – Life with Disease Alagille syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sugammadex Hu5F9‐G4 Irbesartan Phenprocoumon Metoprolol Tartrate Bisoprolol Lumateperone Viltolarsen Inclisiran Sodium Tiotropium AAV9-CTNT-COBAG3 Charcoal, Activated GSKVX000000048110 Abemaciclib Kan-101 Timothy Grass Pollen Extract Inupadenant Hydrochloride Crisantaspase R2R01 Istradefylline More therapies…

    Learn about Your Condition

    Papulopustular rosacea Perinatal depression Lung transplant Oesophagectomy Prostate cancer Spina bifida Microscopic polyangiitis Osteochondrodysplasia Large cell lung cancer stage 0 Tuberculosis Peripheral ischaemia Periarthritis Aplasia pure red cell Tendon injury Adenocarcinoma of colon More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Treating Frontal Fibrosing Alopecia in Adults Using Microneedling and Photodynamic Therapy with Methyl Aminolevulinate Hydrochloride

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lichen planopilaris
    Investigated Drugs:
    • Methyl Aminolevulinate Hydrochloride
    Norway

  • Study of ALXN1850 for Children Aged 2 to 12 with Hypophosphatasia Who Have Not Previously Received Asfotase Alfa Treatment

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Alxn1850
    Belgium Finland France Italy Poland Romania +2

  • Study on Eblasakimab for Adults with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Germany Poland

  • Study on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Alclometasone Dipropionate
    • Anb032
    • Hydrocortisone
    Czechia Poland

  • Evaluation of MC2-25 Cream for Itching in Patients with Chronic Kidney Disease-associated Pruritus

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Chronic kidney disease-associated pruritus
    Germany Hungary Poland

  • Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • Chloropyramine Hydrochloride
    • Chlorphenamine Maleate
    • Clemastine Fumarate
    Austria Croatia Denmark France Germany Greece +6
Previous Page
1 … 28 29 30 31 32 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!